<Zhu>
Case Summary - Kui Zhu
[Federal Register: August 24, 2006 (Volume 71, Number 164)]
[Notices]
[Page 50064]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24au06-58]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Findings of Misconduct in Science
ACTION: Notice.
SUMMARY: Notice is hereby given that the Office of Research Integrity
(ORI) and the Assistant Secretary for Health have taken final action in
the following case:
Kui Zhu, Ph.D., Cleveland Clinic Research Foundation: Based on
accumulated evidence including the Cleveland Clinic Research Foundation
(CCF) investigation report (CCF Report) and additional analysis and
information obtained by the Office of Research Integrity (ORI) during
its oversight review of the CCF Report, the U.S. Public Health Service
(PHS) found that Kui Zhu, Ph.D., former postdoctoral fellow, CCF,
engaged in misconduct in science by intentionally and knowingly
fabricating and falsifying data for figures in two publications and
with research funded by National Cancer Institute (NCI), National
Institutes of Health (NIH), grants R21 CA84038, R01 CA76204, and T32
CA09056.
ORI has implemented the following administrative actions for a
period of three (3) years, beginning June 7, 2006:
(1) Dr. Zhu is debarred from any contracting or subcontracting with
any agency of the United States Government and from eligibility or
involvement in nonprocurement programs of the United States Government
as defined in the debarment regulations at 45 CFR part 76; and
(2) Dr. Zhu is prohibited from serving in any advisory capacity to
PHS, including but not limited to service on any PHS advisory
committee, board, and/or peer review committee, or as a consultant.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative
Oversight
Office of Research Integrity
1101 Wootton Parkway, Suite
750
Rockville, MD 20852
(240) 453-8800
Chris B. Pascal,
Director, Office of Research Integrity.
|
Assurance
